en

PRODUCT DETAIL

Perjeta 420 mg infúzny koncentrát

Code 4491A
MA number EU/1/13/813/001
Product Form: con inf 1x420 mg (liek.inj.skl.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01F MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
L01FD HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors
L01FD02 Pertuzumab
Shelf life: 24
Container: glass vial
Route of admin.: Intravenous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 04.03.2013
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 15.08.2023
eu-flag.png sk-flag.png